Fred T. Lee Jr., MD
Dr. Lee Jr. is a Professor of Radiology, Biomedical Engineering, and Urology, The Robert A. Turrell Professor of Imaging Science, and Chief, Abdominal Intervention at the University of Wisconsin Department of Radiology. Dr. Lee has special interests in cancer imaging and interventions with an emphasis on percutaneous tumor ablation. As an early pioneer in the field, he established the tumor ablation laboratory at Wisconsin in 1995, one of the first of its type in the world. His work has resulted in over 250 scientific publications, 22 book chapters, greater than 60 major awards, including multiple “Best Doctor” awards, 25 patents and inventions, and substantial federal and industrial grant support. The UW Clinical Tumor Ablation Program draws patients from all over the world to Madison for cancer treatment. He is an inventor of two of the world’s most widely applied tumor ablation devices used for cure, prolongation of life, or relief of symptoms in over 50,000 cancer patients. Another of his inventions was recently designated as a Breakthrough Device by the FDA. Dr. Lee is a founder of two venture-backed medical device companies: Elucent Medical, Inc., and NeuWave Medical Inc., a University of Wisconsin spin-off company which sold to Ethicon (Johnson & Johnson) in 2016, and is a board member and Senior Medical Advisor for Histosonics, Inc., a University of Michigan spin-off company.